How HealthLocator can help patients find high-quality care while building trust, improving transparency, and supporting ...

Can a scalable, technology-enabled platform make value-based care work across fragmented health care systems? Early results ...

Mount Sinai Health System has implemented an evidence-based, AI-driven digital symptom checker, “Check Symptoms & Get Care” (CSGC), deployed at scale across its public website and patient portal mo ...

An innovation team at the University of Pennsylvania Health System demonstrates how an automated text-messaging system can remotely monitor patients with confirmed or suspected Covid-19 at home and ...

How can health system leaders move beyond treating gun violence as an injury event to address it as a preventable public health crisis?

This article critically examines the potential impacts of artificial intelligence (AI) on prices, total spending, and the rate of spending growth in the areas of prescription drug innovation and ...

Hospital-associated functional decline resulting from immobility and prolonged bed rest is a widespread yet underrecognized complication in acute care. Despite strong evidence linking immobility ...

Physician leadership roles now demand competencies beyond clinical expertise. Although skills and training models have been described, not much is known about the development pathways and operational ...

NEJM Catalyst Insights Council members say end-of-life care must balance intertwined and sometimes conflicting priorities, including living as long as possible, avoiding suffering, maximizing dignity, ...

As health care transitions from fee-for-service (FFS) to value-based care (VBC), models that effectively integrate mental and physical health are essential, particularly considering the unsustainable ...

Timely access to dermatologic care remains a persistent challenge, particularly for new patient visits (NPVs), for which long lead times can delay diagnosis and treatment of serious conditions such as ...

At a Veterans Affairs medical center, an immunotherapy stewardship initiative was developed to optimize dosing of pembrolizumab, which accounted for Medicare Part B’s largest single line item for ...